{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:46:30Z","timestamp":1791193590987,"version":"4.1.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1002\/jps.23584","type":"journal-article","created":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T20:21:38Z","timestamp":1367958098000},"page":"3037-3057","source":"Crossref","is-referenced-by-count":113,"title":["An updated review on drug-induced cholestasis: Mechanisms and investigation of physicochemical properties and pharmacokinetic parameters"],"prefix":"10.1016","volume":"102","author":[{"given":"Kyunghee","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"K\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sedykh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tropsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim L.R.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1002\/jps.23584_bb0010","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","article-title":"Drug-induced hepatotoxicity","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1002\/jps.23584_bb0015","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"Benichou","year":"1990","journal-title":"J Hepatol"},{"issue":"2","key":"10.1002\/jps.23584_bb0020","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bjornsson","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/jps.23584_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2796.1992.tb00562.x","article-title":"Drug-induced hepatic injury: An analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987","volume":"232","author":"Friis","year":"1992","journal-title":"J Intern Med"},{"issue":"5","key":"10.1002\/jps.23584_bb0030","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0025-7125(05)70287-X","article-title":"Drug-induced liver disease","volume":"84","author":"Lewis","year":"2000","journal-title":"Med Clin North Am"},{"issue":"4","key":"10.1002\/jps.23584_bb0035","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"issue":"5 Pt 1","key":"10.1002\/jps.23584_bb0040","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0016-5085(79)91333-7","article-title":"Erythromycin ethylsuccinate-induced cholestasis","volume":"76","author":"Viteri","year":"1979","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/jps.23584_bb0045","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.1840200610","article-title":"Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis","volume":"20","author":"Moradpour","year":"1994","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1002\/jps.23584_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(97)82326-4","article-title":"Drug-induced cholestasis","volume":"26","author":"Erlinger","year":"1997","journal-title":"J Hepatol"},{"issue":"2","key":"10.1002\/jps.23584_bb0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1089-3261(03)00028-X","article-title":"Bile duct disorders","volume":"7","author":"Geubel","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1002\/jps.23584_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"10.1002\/jps.23584_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/156652407780059168","article-title":"Enzymes in the conversion of cholesterol into bile acids","volume":"7","author":"Norlin","year":"2007","journal-title":"Curr Mol Med"},{"issue":"10","key":"10.1002\/jps.23584_bb0070","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: Regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1002\/jps.23584_bb0075","series-title":"The liver: Biology and pathobiology","article-title":"Bile Acids","author":"Hofmann","year":"1994"},{"issue":"3","key":"10.1002\/jps.23584_bb0080","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1152\/ajplegacy.1976.231.3.734","article-title":"Uptake of bile acids by perfused rat liver","volume":"231","author":"Reichen","year":"1976","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1002\/jps.23584_bb0085","first-page":"G484","article-title":"Bile acid transport in cultured rat hepatocytes","volume":"243","author":"Van Dyke","year":"1982","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1002\/jps.23584_bb0090","first-page":"1043","article-title":"Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes","volume":"286","author":"Kouzuki","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1002\/jps.23584_bb0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/toxsci\/kfr014","article-title":"Differential disposition of chenodeoxycholic acid versus taurocholic acid in response to acute troglitazone exposure in rat hepatocytes","volume":"120","author":"Marion","year":"2011","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1002\/jps.23584_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1388-1981(00)00057-3","article-title":"Intracellular transport of bile acids","volume":"1486","author":"Agellon","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"2 Pt 1","key":"10.1002\/jps.23584_bb0105","first-page":"G298","article-title":"Lack of evidence for vesicle trafficking of fluorescent bile salts in rat hepatocyte couplets","volume":"272","author":"El-Seaidy","year":"1997","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1002\/jps.23584_bb0110","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.21359","article-title":"Hepatobiliary transporters and drug-induced cholestasis","volume":"44","author":"Pauli-Magnus","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/jps.23584_bb0115","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/gast.2001.28648","article-title":"Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia","volume":"121","author":"Rost","year":"2001","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/jps.23584_bb0120","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.20961","article-title":"OSTalpha-OSTbeta: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia","volume":"42","author":"Ballatori","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/jps.23584_bb0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1023\/A:1013699130991","article-title":"Transport activity of human MRP3 expressed in Sf9 cells: Comparative studies with rat MRP3","volume":"19","author":"Akita","year":"2002","journal-title":"Pharm Res"},{"issue":"4","key":"10.1002\/jps.23584_bb0130","doi-asserted-by":"crossref","first-page":"G640","DOI":"10.1152\/ajpgi.00354.2005","article-title":"Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione","volume":"290","author":"Rius","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"10.1002\/jps.23584_bb0135","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/153537020523001001","article-title":"Biology of a novel organic solute and steroid transporter, OSTalpha-OSTbeta","volume":"230","author":"Ballatori","year":"2005","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1002\/jps.23584_bb0140","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2741\/3416","article-title":"OST alpha-OST beta: A key membrane transporter of bile acids and conjugated steroids","volume":"14","author":"Ballatori","year":"2009","journal-title":"Front Biosci"},{"issue":"8","key":"10.1002\/jps.23584_bb0145","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1023\/A:1010918825019","article-title":"Sinusoidal efflux of taurocholate is enhanced in Mrp2-deficient rat liver","volume":"18","author":"Akita","year":"2001","journal-title":"Pharm Res"},{"issue":"4 Suppl 2","key":"10.1002\/jps.23584_bb0150","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1097\/01.mcg.0000155551.37266.26","article-title":"Molecular regulation of hepatobiliary transport systems: Clinical implications for understanding and treating cholestasis","volume":"39","author":"Trauner","year":"2005","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"10.1002\/jps.23584_bb0155","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1478-3231.2007.01506.x","article-title":"Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis","volume":"27","author":"Zollner","year":"2007","journal-title":"Liver Int"},{"issue":"3","key":"10.1002\/jps.23584_bb0160","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.bjp.0707235","article-title":"Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis","volume":"151","author":"Teng","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1002\/jps.23584_bb0165","doi-asserted-by":"crossref","first-page":"G1124","DOI":"10.1152\/ajpgi.00539.2005","article-title":"Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents","volume":"290","author":"Boyer","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"21","key":"10.1002\/jps.23584_bb0170","doi-asserted-by":"crossref","first-page":"22250","DOI":"10.1074\/jbc.M314111200","article-title":"Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice","volume":"279","author":"Assem","year":"2004","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1002\/jps.23584_bb0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/toxsci\/kfn268","article-title":"Bile acid sulfation: A pathway of bile acid elimination and detoxification","volume":"108","author":"Alnouti","year":"2009","journal-title":"Toxicol Sci"},{"issue":"22","key":"10.1002\/jps.23584_bb0180","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","article-title":"The continuing importance of bile acids in liver and intestinal disease","volume":"159","author":"Hofmann","year":"1999","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1002\/jps.23584_bb0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-2275(20)43096-2","article-title":"Mechanisms for the intestinal absorption of bile acids","volume":"9","author":"Dietschy","year":"1968","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1002\/jps.23584_bb0190","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00005176-200104000-00002","article-title":"Intestinal bile acid transport: Biology, physiology, and pathophysiology","volume":"32","author":"Shneider","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1002\/jps.23584_bb0195","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00424-003-1130-z","article-title":"The sodium bile salt cotransport family SLC10","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch"},{"issue":"8","key":"10.1002\/jps.23584_bb0200","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1074\/jbc.M412752200","article-title":"The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter","volume":"280","author":"Dawson","year":"2005","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1002\/jps.23584_bb0205","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1073\/pnas.0712328105","article-title":"The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1002\/jps.23584_bb0210","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","article-title":"Bile salt transporters: Molecular characterization, function, and regulation","volume":"83","author":"Trauner","year":"2003","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1002\/jps.23584_bb0215","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bcp.2009.08.029","article-title":"Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil","volume":"79","author":"Ming","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"3\u20135","key":"10.1002\/jps.23584_bb0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jsbmb.2011.06.012","article-title":"FXR and PXR: Potential therapeutic targets in cholestasis","volume":"130","author":"Jonker","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"10.1002\/jps.23584_bb0225","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","article-title":"The Farnesoid X receptor: A molecular link between bile acid and lipid and glucose metabolism","volume":"25","author":"Claudel","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"10.1002\/jps.23584_bb0230","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1002\/jps.23584_bb0235","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","article-title":"A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation","volume":"101","author":"Rodrigues","year":"1998","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1002\/jps.23584_bb0240","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/gast.1997.v113.pm9352877","article-title":"Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes","volume":"113","author":"Roberts","year":"1997","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/jps.23584_bb0245","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2353\/ajpath.2006.050404","article-title":"Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice","volume":"168","author":"Fickert","year":"2006","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1002\/jps.23584_bb0250","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0014-5793(85)81257-6","article-title":"Bile acid binding in plasma: The importance of lipoproteins","volume":"187","author":"Salvioli","year":"1985","journal-title":"FEBS Lett"},{"key":"10.1002\/jps.23584_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-4-1","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"Davit-Spraul","year":"2009","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1002\/jps.23584_bb0260","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/gut.2008.159541","article-title":"Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy","volume":"58","author":"Dixon","year":"2009","journal-title":"Gut"},{"issue":"1","key":"10.1002\/jps.23584_bb0265","doi-asserted-by":"crossref","first-page":"G58","DOI":"10.1152\/ajpgi.00367.2007","article-title":"Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells","volume":"294","author":"Kagawa","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1002\/jps.23584_bb0270","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.110.165852","article-title":"Sulindac and its metabolites inhibit multiple transport proteins in rat and human hepatocytes","volume":"334","author":"Lee","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1002\/jps.23584_bb0275","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1002\/jps.23584_bb0280","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0016-5085(94)90084-1","article-title":"Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver","volume":"107","author":"Bohme","year":"1994","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/jps.23584_bb0285","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0300-483X(01)00460-7","volume":"167","author":"Funk","year":"2001","journal-title":"Toxicology"},{"issue":"9","key":"10.1002\/jps.23584_bb0290","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1124\/dmd.108.024778","article-title":"Effect of membrane cholesterol on BSEP\/Bsep activity: Species specificity studies for substrates and inhibitors","volume":"37","author":"Kis","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1002\/jps.23584_bb0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/bdd.527","article-title":"Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2","volume":"28","author":"Mano","year":"2007","journal-title":"Biopharm Drug Dispos"},{"issue":"2","key":"10.1002\/jps.23584_bb0300","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"Morgan","year":"2010","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1002\/jps.23584_bb0305","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","article-title":"In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans","volume":"40","author":"Dawson","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1002\/jps.23584_bb0310","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/jps.23584_bb0315","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0168-8278(02)00107-1","article-title":"Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan","volume":"37","author":"Fouassier","year":"2002","journal-title":"J Hepatol"},{"issue":"11","key":"10.1002\/jps.23584_bb0320","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/BC20040088","article-title":"Biliary lipids, water and cholesterol gallstones","volume":"97","author":"van Erpecum","year":"2005","journal-title":"Biol Cell"},{"key":"10.1002\/jps.23584_bb0325","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.2741\/3526","article-title":"Liver diseases related to MDR3 (ABCB4) gene deficiency","volume":"14","author":"Gonzales","year":"2009","journal-title":"Front Biosci"},{"issue":"2","key":"10.1002\/jps.23584_bb0330","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/mol.110.067256","article-title":"Itraconazole-induced cholestasis: Involvement of the inhibition of bile canalicular phospholipid translocator MDR3\/ABCB4","volume":"79","author":"Yoshikado","year":"2011","journal-title":"Mol Pharmacol"},{"issue":"31","key":"10.1002\/jps.23584_bb0335","doi-asserted-by":"crossref","first-page":"23530","DOI":"10.1074\/jbc.M909002199","article-title":"MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping","volume":"275","author":"Smith","year":"2000","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1002\/jps.23584_bb0340","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jhep.2003.12.001","article-title":"Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat","volume":"40","author":"Denk","year":"2004","journal-title":"J Hepatol"},{"issue":"4","key":"10.1002\/jps.23584_bb0345","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2174\/138920111795163986","article-title":"ABC transporters, bile acids, and inflammatory stress in liver cancer","volume":"12","author":"Wang","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"issue":"5","key":"10.1002\/jps.23584_bb0350","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.20682","article-title":"Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis","volume":"41","author":"Keitel","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/jps.23584_bb0355","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s11605-011-1473-2","article-title":"Changes of organic anion transporter MRP4 and related nuclear receptors in human obstructive cholestasis","volume":"15","author":"Chai","year":"2011","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"10.1002\/jps.23584_bb0360","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/jhep.2001.23501","article-title":"Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver","volume":"33","author":"Soroka","year":"2001","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/jps.23584_bb0365","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/jhep.2001.26213","article-title":"Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver","volume":"34","author":"Donner","year":"2001","journal-title":"Hepatology"},{"key":"10.1002\/jps.23584_bb0370","series-title":"2011 AAPS Annual Meeting and Exposition","first-page":"M1301","article-title":"Interaction of troglitazone sulfate with hepatic basolateral and canalicular transport proteins","author":"Yang","year":"2011"},{"key":"10.1002\/jps.23584_bb0375","series-title":"SOT Annual Meeting and ToxExpo","first-page":"495","article-title":"Inhibition of hepatic bile acid transporter MRP4: A potential risk factor for drug-induced liver injury (DILI)","author":"K\u00f6ck","year":"2011"},{"key":"10.1002\/jps.23584_bb0380","series-title":"AASLD Liver Meeting","article-title":"Inhibition of the hepatic basolateral bile acid transporter MRP4 predicts cholestatic drug-induced liver injury (DILI)","author":"K\u00f6ck","year":"2012"},{"issue":"3","key":"10.1002\/jps.23584_bb0385","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/jpet.106.119073","article-title":"Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP\/SLC10A1)by bosentan: A mechanism for species differences in hepatotoxicity","volume":"321","author":"Leslie","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1002\/jps.23584_bb0390","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/mp0700357","article-title":"Use of sandwich-cultured hepatocytes to evaluate impaired bile acid transport as a mechanism of drug-induced hepatotoxicity","volume":"4","author":"Marion","year":"2007","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1002\/jps.23584_bb0395","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/dmd.109.028407","article-title":"An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes","volume":"38","author":"Ansede","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1002\/jps.23584_bb0400","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/toxsci\/kfi020","article-title":"Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes","volume":"83","author":"Kemp","year":"2005","journal-title":"Toxicol Sci"},{"issue":"2","key":"10.1002\/jps.23584_bb0405","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/clpt.2011.124","article-title":"Profile of serum bile acids in noncholestatic volunteers: Gender-related differences in response to fenofibrate","volume":"90","author":"Trottier","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1002\/jps.23584_bb0410","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/BF01317087","article-title":"Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes","volume":"29","author":"Miyazaki","year":"1984","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1002\/jps.23584_bb0415","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1194\/jlr.M700351-JLR200","article-title":"FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption","volume":"48","author":"Jung","year":"2007","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1002\/jps.23584_bb0420","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3468(98)90435-3","article-title":"Ileal exclusion for Byler's disease: An alternative surgical approach with promising early results for pruritus","volume":"33","author":"Hollands","year":"1998","journal-title":"J Pediatr Surg"},{"issue":"12","key":"10.1002\/jps.23584_bb0425","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/0022-3468(95)90440-9","article-title":"Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease)","volume":"30","author":"Emond","year":"1995","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1002\/jps.23584_bb0430","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0016-5085(88)90301-0","article-title":"Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis","volume":"95","author":"Whitington","year":"1988","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/jps.23584_bb0435","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1073\/pnas.0409794102","article-title":"Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury","volume":"102","author":"Stedman","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1002\/jps.23584_bb0440","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1124\/dmd.108.023317","article-title":"Constitutive androstane receptor-mediated changes in bile acid composition contributes to hepatoprotection from lithocholic acid-induced liver injury in mice","volume":"37","author":"Beilke","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1002\/jps.23584_bb0445","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/mp060010s","article-title":"Role of nuclear receptors in the adaptive response to bile acids and cholestasis: Pathogenetic and therapeutic considerations","volume":"3","author":"Zollner","year":"2006","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1002\/jps.23584_bb0450","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbamcr.2006.04.014","article-title":"Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration","volume":"1773","author":"Geier","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1002\/jps.23584_bb0455","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0041-008X(92)90323-K","article-title":"Effect of pregnenolone-16 alpha-carbonitrile and dexamethasone on acetaminophen-induced hepatotoxicity in mice","volume":"115","author":"Madhu","year":"1992","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"10.1002\/jps.23584_bb0460","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/1099-1263(200011\/12)20:6<427::AID-JAT707>3.0.CO;2-#","article-title":"Effects of benzothiazole on the xenobiotic metabolizing enzymes and metabolism of acetaminophen","volume":"20","author":"Seo","year":"2000","journal-title":"J Appl Toxicol"},{"issue":"30","key":"10.1002\/jps.23584_bb0465","doi-asserted-by":"crossref","first-page":"11323","DOI":"10.1073\/pnas.0604772103","article-title":"Benefit of farnesoid X receptor inhibition in obstructive cholestasis","volume":"103","author":"Stedman","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1002\/jps.23584_bb0470","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbagrm.2011.01.008","article-title":"Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter","volume":"1809","author":"Renga","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"10.1002\/jps.23584_bb0475","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/03602539709037580","article-title":"Cholestatic properties and hepatic transport of steroid glucuronides","volume":"29","author":"Vore","year":"1997","journal-title":"Drug Metab Rev"},{"issue":"3","key":"10.1002\/jps.23584_bb0480","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0304-4165(69)90321-3","article-title":"The mechanism of glucocorticoid action on the phytohemagglutinin-stimulated lymphocyte. I. In vitro binding of corticosteroids to lymphoid tissue","volume":"177","author":"Eurenius","year":"1969","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1002\/jps.23584_bb0485","doi-asserted-by":"crossref","first-page":"G449","DOI":"10.1152\/ajpgi.00508.2002","article-title":"Estradiol-17beta-d-glucuronide induces endocytic internalization of Bsep in rats","volume":"285","author":"Crocenzi","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1002\/jps.23584_bb0490","doi-asserted-by":"crossref","first-page":"G327","DOI":"10.1152\/ajpgi.00227.2004","article-title":"Role of microtubules in estradiol-17beta-D-glucuronide-induced alteration of canalicular Mrp2 localization and activity","volume":"288","author":"Mottino","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"10.1002\/jps.23584_bb0495","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1053\/jhep.2002.33327","article-title":"Altered localization and activity of canalicular Mrp2 in estradiol-17beta-d-glucuronide-induced cholestasis","volume":"35","author":"Mottino","year":"2002","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/jps.23584_bb0500","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1085\/jgp.11.4.357","article-title":"The phosphate ion and hydrolysis by pancreatic lipase","volume":"11","author":"Dawson","year":"1928","journal-title":"J Gen Physiol"},{"issue":"4","key":"10.1002\/jps.23584_bb0505","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/hep.23846","article-title":"Phosphoinositide 3-kinase\/protein kinase B signaling pathway is involved in estradiol 17beta-d-glucuronide-induced cholestasis: Complementarity with classical protein kinase C","volume":"52","author":"Boaglio","year":"2010","journal-title":"Hepatology"},{"issue":"11","key":"10.1002\/jps.23584_bb0510","doi-asserted-by":"crossref","first-page":"e50711","DOI":"10.1371\/journal.pone.0050711","article-title":"Sequential activation of classic PKC and estrogen receptor alpha is involved in estradiol 17ss-d-glucuronide-induced cholestasis","volume":"7","author":"Barosso","year":"2012","journal-title":"PLoS ONE"},{"issue":"24","key":"10.1002\/jps.23584_bb0515","doi-asserted-by":"crossref","first-page":"16625","DOI":"10.1074\/jbc.M602723200","article-title":"Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity","volume":"281","author":"Yamamoto","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1002\/jps.23584_bb0520","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/dmd.112.047357","article-title":"Induction of hepatic multidrug resistance associated protein 3 by ethynylestradiol is independent of cholestasis and mediated by estrogen receptor","volume":"41","author":"Ruiz","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1002\/jps.23584_bb0525","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1046\/j.1440-1746.1999.01982.x","article-title":"Inflammation-induced cholestasis","volume":"14","author":"Trauner","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1002\/jps.23584_bb0530","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0016-5085(97)70250-6","article-title":"Sepsis-associated cholestasis","volume":"112","author":"Moseley","year":"1997","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/jps.23584_bb0535","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1248\/bpb.31.412","article-title":"Effect of aminoguanidine on lipopolysaccharide-induced changes in rat liver transporters and transcription factors","volume":"31","author":"Aoki","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.23584_bb0540","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolizing enzymes and transporters in inflammation","volume":"46","author":"Aitken","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"10.1002\/jps.23584_bb0545","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jemt.20184","article-title":"Experimental LPS-induced cholestasis alters subcellular distribution and affects colocalization of Mrp2 and Bsep proteins: A quantitative colocalization study","volume":"67","author":"Zinchuk","year":"2005","journal-title":"Microsc Res Tech"},{"issue":"2","key":"10.1002\/jps.23584_bb0550","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0016-5085(99)70138-1","article-title":"Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone","volume":"116","author":"Kubitz","year":"1999","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/jps.23584_bb0555","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.1074\/jbc.275.12.8835","article-title":"Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation","volume":"275","author":"Denson","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1002\/jps.23584_bb0560","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1478-1336-2-4","article-title":"Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: A novel mechanism for reduced hepatic gene expression in inflammation","volume":"2","author":"Ghose","year":"2004","journal-title":"Nucl Recept"},{"issue":"10","key":"10.1002\/jps.23584_bb0565","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1172\/JCI1680","article-title":"Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors","volume":"101","author":"Trauner","year":"1998","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1002\/jps.23584_bb0570","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(03)00096-5","article-title":"Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis","volume":"38","author":"Zollner","year":"2003","journal-title":"J Hepatol"},{"issue":"5","key":"10.1002\/jps.23584_bb0575","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0168-8278(03)00410-0","article-title":"Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis","volume":"39","author":"Kojima","year":"2003","journal-title":"J Hepatol"},{"issue":"6","key":"10.1002\/jps.23584_bb0580","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1440-1746.2009.05800.x","article-title":"Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease","volume":"24","author":"Congiu","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1002\/jps.23584_bb0585","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1089-3261(03)00032-1","article-title":"Drug-induced cholestasis","volume":"7","author":"Levy","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1002\/jps.23584_bb0590","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1089-3261(03)00124-7","article-title":"Drug- and chemical-induced cholestasis","volume":"8","author":"Mohi-ud-din","year":"2004","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1002\/jps.23584_bb0595","first-page":"113","article-title":"Drug-induced cholestasis","volume":"12","author":"Chitturi","year":"2001","journal-title":"Semin Gastrointest Dis"},{"key":"10.1002\/jps.23584_bb0600","series-title":"Drug-induced cholestasis","author":"Hamilton","year":"2008"},{"issue":"12","key":"10.1002\/jps.23584_bb0605","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1124\/dmd.112.047068","article-title":"Mitigating the inhibition of human bile salt export pump by drugs: Opportunities provided by physicochemical property modulation, in silico modeling, and structural modification","volume":"40","author":"Warner","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1002\/jps.23584_bb0610","first-page":"24","article-title":"Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1\/P-glycoprotein","volume":"57","author":"Lecureur","year":"2000","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1002\/jps.23584_bb0615","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1053\/jhep.2001.24171","article-title":"Characterization of the mouse bile salt export pump overexpressed in the baculovirus system","volume":"33","author":"Noe","year":"2001","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/jps.23584_bb0620","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.36591","article-title":"The human bile salt export pump: Characterization of substrate specificity and identification of inhibitors","volume":"123","author":"Byrne","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/jps.23584_bb0625","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1023\/A:1023278211849","article-title":"Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: Evidence for contingent unequal binding sites","volume":"20","author":"Wang","year":"2003","journal-title":"Pharm Res"},{"issue":"3","key":"10.1002\/jps.23584_bb0630","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/mp060004w","article-title":"High-speed screening and QSAR analysis of human ATP-binding cassette transporter ABCB11 (bile salt export pump) to predict drug-induced intrahepatic cholestasis","volume":"3","author":"Hirano","year":"2006","journal-title":"Mol Pharm"},{"key":"10.1002\/jps.23584_bb0635","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-013-1023-6","article-title":"The use of pseudo-equilibrium constant affords improved QSAR models of human plasma protein binding","author":"Zhu","year":"2013","journal-title":"Pharm Res"},{"issue":"4","key":"10.1002\/jps.23584_bb0640","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","article-title":"BDDCS applied to over 900 drugs","volume":"13","author":"Benet","year":"2011","journal-title":"AAPS J"},{"key":"10.1002\/jps.23584_bb0645","series-title":"Chemical biology: From small molecules to systems biology and drug design","first-page":"760","article-title":"WOMBAT and WOMBAT-PK: Bioactivity databases for lead and drug discovery.","author":"Olah","year":"2007"},{"key":"10.1002\/jps.23584_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/0471140856.tx2305s54","article-title":"Membrane vesicle ABC transporter assays for drug safety assessment","author":"van Staden","year":"2012","journal-title":"Curr Protoc Toxicol"},{"key":"10.1002\/jps.23584_bb0655","doi-asserted-by":"crossref","first-page":"e005","DOI":"10.1621\/nrs.08005","article-title":"Deciphering the nuclear bile acid receptor FXR paradigm","volume":"8","author":"Modica","year":"2010","journal-title":"Nucl Recept Signal"},{"issue":"6","key":"10.1002\/jps.23584_bb0660","doi-asserted-by":"crossref","first-page":"G926","DOI":"10.1152\/ajpgi.00044.2002","article-title":"Nuclear receptors. I. Nuclear receptors and bile acid homeostasis","volume":"282","author":"Goodwin","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"10.1002\/jps.23584_bb0665","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1208\/s12248-009-9137-9","article-title":"Technical pitfalls and improvements for high-speed screening and QSAR analysis to predict inhibitors of the human bile salt export pump (ABCB11\/BSEP)","volume":"11","author":"Saito","year":"2009","journal-title":"AAPS J"},{"issue":"5","key":"10.1002\/jps.23584_bb0670","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ejps.2005.07.008","article-title":"Quantitative structure\u2013activity relationships of methotrexate and methotrexate analogues transported by the rat multispecific resistance-associated protein 2 (rMrp2)","volume":"26","author":"Ng","year":"2005","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"10.1002\/jps.23584_bb0675","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1021\/jm7015683","article-title":"Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)","volume":"51","author":"Pedersen","year":"2008","journal-title":"J Med Chem"},{"issue":"4\u20135","key":"10.1002\/jps.23584_bb0680","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejps.2008.11.014","article-title":"Support vector machine and pharmacophore-based prediction models of multidrug-resistance protein 2 (MRP2) inhibitors","volume":"36","author":"Zhang","year":"2009","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1002\/jps.23584_bb0685","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s11095-012-0935-x","article-title":"Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions","volume":"30","author":"Sedykh","year":"2012","journal-title":"Pharm Res"},{"issue":"7","key":"10.1002\/jps.23584_bb0690","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s11095-009-9877-3","article-title":"Inhibition requirements of the human apical sodium-dependent bile acid transporter (hASBT) using aminopiperidine conjugates of glutamyl-bile acids","volume":"26","author":"Gonzalez","year":"2009","journal-title":"Pharm Res"},{"issue":"5","key":"10.1002\/jps.23584_bb0695","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1021\/mp900163d","article-title":"Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter","volume":"6","author":"Zheng","year":"2009","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1002\/jps.23584_bb0700","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1021\/bc100273w","article-title":"Structural requirements of the ASBT by 3D-QSAR analysis using aminopyridine conjugates of chenodeoxycholic acid","volume":"21","author":"Zheng","year":"2010","journal-title":"Bioconjug Chem"},{"issue":"6","key":"10.1002\/jps.23584_bb0705","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1021\/mp100233v","article-title":"Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates","volume":"7","author":"Rais","year":"2010","journal-title":"Mol Pharm"},{"issue":"12","key":"10.1002\/jps.23584_bb0710","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1021\/jm1003683","article-title":"Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter","volume":"53","author":"Rais","year":"2010","journal-title":"J Med Chem"},{"issue":"1","key":"10.1002\/jps.23584_bb0715","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/toxsci\/kfs188","article-title":"In silico identification of potential cholestasis-inducing agents via modeling of Na(+)-dependent taurocholate cotransporting polypeptide substrate specificity","volume":"129","author":"Greupink","year":"2012","journal-title":"Toxicol Sci"},{"issue":"10","key":"10.1002\/jps.23584_bb0720","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/jm300212s","article-title":"Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): Influence of protein expression on drug-drug interactions","volume":"55","author":"Karlgren","year":"2012","journal-title":"J Med Chem"},{"issue":"2","key":"10.1002\/jps.23584_bb0725","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11095-011-0564-9","article-title":"In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions","volume":"29","author":"Karlgren","year":"2012","journal-title":"Pharm Res"},{"issue":"6","key":"10.1002\/jps.23584_bb0730","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2133\/dmpk.DMPK-11-RG-063","article-title":"Molecular-weight-dependent, anionic-substrate-preferential transport of beta-lactam antibiotics via multidrug resistance-associated protein 4","volume":"26","author":"Akanuma","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"issue":"3","key":"10.1002\/jps.23584_bb0735","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1002\/jps.23584_bb0740","doi-asserted-by":"crossref","first-page":"e1000594","DOI":"10.1371\/journal.pcbi.1000594","article-title":"Challenges predicting ligand-receptor interactions of promiscuous proteins: The nuclear receptor PXR","volume":"5","author":"Ekins","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"10.1002\/jps.23584_bb0745","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-62703-050-2_15","article-title":"Ligand- and structure-based pregnane X receptor models","volume":"929","author":"Kortagere","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"7","key":"10.1002\/jps.23584_bb0750","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/tx800102e","article-title":"Machine learning methods and docking for predicting human pregnane X receptor activation","volume":"21","author":"Khandelwal","year":"2008","journal-title":"Chem Res Toxicol"},{"issue":"4","key":"10.1002\/jps.23584_bb0755","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s11095-008-9809-7","article-title":"Hybrid scoring and classification approaches to predict human pregnane X receptor activators","volume":"26","author":"Kortagere","year":"2009","journal-title":"Pharm Res"},{"issue":"6","key":"10.1002\/jps.23584_bb0760","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jmgm.2006.09.003","article-title":"3D QSAR comparative molecular field analysis on nonsteroidal farnesoid X receptor activators","volume":"25","author":"Honorio","year":"2007","journal-title":"J Mol Graph Model"},{"issue":"8","key":"10.1002\/jps.23584_bb0765","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.bmcl.2007.01.079","article-title":"3D-QSAR studies with the aid of molecular docking for a series of non-steroidal FXR agonists","volume":"17","author":"Zhang","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"issue":"18","key":"10.1002\/jps.23584_bb0770","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1016\/j.bmc.2012.04.020","article-title":"Development of in silico filters to predict activation of the pregnane X receptor (PXR) by structurally diverse drug-like molecules","volume":"20","author":"Matter","year":"2012","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"10.1002\/jps.23584_bb0775","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/mol.106.027623","article-title":"In silico prediction of pregnane X receptor activators by machine learning approaches","volume":"71","author":"Ung","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1002\/jps.23584_bb0780","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.taap.2012.05.008","article-title":"QSAR model for human pregnane X receptor (PXR) binding: Screening of environmental chemicals and correlations with genotoxicity, endocrine disruption and teratogenicity","volume":"262","author":"Dybdahl","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"issue":"12","key":"10.1002\/jps.23584_bb0785","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1016\/j.bmcl.2005.04.017","article-title":"Hologram quantitative structure\u2013activity relationships for a series of farnesoid X receptor activators","volume":"15","author":"Honorio","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1002\/jps.23584_bb0790","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1021\/jm900872z","article-title":"Structure\u2013activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: Potential impact in diabetes","volume":"53","author":"Genet","year":"2010","journal-title":"J Med Chem"},{"issue":"23","key":"10.1002\/jps.23584_bb0795","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1016\/j.bmc.2011.09.056","article-title":"Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation","volume":"19","author":"Schuster","year":"2011","journal-title":"Bioorg Med Chem"},{"issue":"22","key":"10.1002\/jps.23584_bb0800","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1016\/j.bmc.2011.09.039","article-title":"Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidum","volume":"19","author":"Grienke","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1002\/jps.23584_bb0805","first-page":"204","article-title":"A multi-scale modeling framework for individualized, spatiotemporal prediction of drug effects and toxicological risk","volume":"3","author":"Diaz Ochoa","year":"2012","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1002\/jps.23584_bb0810","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10928-012-9266-0","article-title":"In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym: A mechanistic, mathematical model of DILI","volume":"39","author":"Howell","year":"2012","journal-title":"J Pharmacokinet Pharmacodyn"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915309394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915309394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T06:28:50Z","timestamp":1644992930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915309394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":161,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0022354915309394"],"URL":"https:\/\/doi.org\/10.1002\/jps.23584","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}